Study of VBC101 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called VBC101 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if VBC101 is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have an advanced solid tumor that cannot be removed with surgery and has worsened after standard treatments or you cannot take standard treatments.
- You must be at least 18 years old.
- You must have good organ and bone marrow function.
- You must have an archived tumor sample or be able to provide a new tissue sample.
- You must not have had prior treatment with certain targeted drug combinations or a similar drug carrying a specific chemotherapy payload.
- You must not have uncontrolled brain metastases or a history of certain lung diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, VBC103, for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink or slow the growth of these tumors.
This trial tests a new drug called VBC106 for people with advanced solid tumors that have not responded to other treatments. It is the first time this drug is being tested in humans, and aims to see if it is safe and helps shrink tumors.
This trial tests an experimental drug called VBC108 in people with advanced solid tumors that have not responded to other treatments. The study aims to see if the drug is safe and effective.
This trial tests a new drug for people with advanced solid tumors that have spread or can't be removed. The drug targets specific proteins on cancer cells to try to shrink or slow the cancer.
This trial tests a new drug called VC004 for people with advanced solid tumors that have spread. It aims to see if the drug can shrink tumors or slow their growth.
This trial tests a new drug called VIB305 in people with advanced solid tumors that have not responded to other treatments. The goal is to see if VIB305 is safe and how it affects the tumors.
Hear when a new Participants With Advanced Solid Tumor Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.